Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL5775702 | 0.97 | ALDH1A1 (0.37) | ALDH1A1L3MBTL1SMN1; SMN2HSP90AB1 | |
| SCHEMBL4734595 | 0.85 | HSP90AB1 (0.35) | ALDH1A1SMN1; SMN2HSP90AB1KDM4ELMNA | |
| SCHEMBL5207542 | 0.82 | ALDH1A1 (0.39) | ALDH1A1L3MBTL1HSP90AB1KDM4ELMNA | |
| SCHEMBL12368143 | 0.81 | ALDH1A1 (0.40) | ALDH1A1L3MBTL1SMN1; SMN2HSP90AB1KDM4E | |
| SCHEMBL5561175 | 0.78 | ALDH1A1 (0.31) | ALDH1A1SMN1; SMN2HSP90AB1 | |
| Hydrochloric Acid SCHEMBL5555790 | 0.76 | ALDH1A1 (0.31) | ALDH1A1SMN1; SMN2HSP90AB1 | |
| SCHEMBL31347383 | 0.74 | EGLN1 (0.38) | — | |
| SCHEMBL1396931 | 0.74 | LMNA (0.35) | ALDH1A1L3MBTL1SMN1; SMN2HSP90AB1KDM4E | |
| SCHEMBL9003122 | 0.74 | EGLN1 (0.31) | — | |
| SCHEMBL10997607 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030199531-A1 | YIGSR peptidomimetics and methods for using the same | UNITED STATES GOVERNMENT SECRETARY OF THE ARMY ARMY MEDICAL RESEARCH AND MATERIEL COMMAND | 2003-10-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030199531-A1 | YIGSR peptidomimetics and methods for using the same | PNISR, SRRM2, ARGLU1 | ALDH1A1 4538/4885L3MBTL1 121/4885SMN1; SMN2 1680/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.